NAS10028,457+0.98%S&P7,679+1.46%GOLD$4,060+3.05%BTC$80,548+4.14%VIX17.57−15.65%latest tape · as of 16:09 UTC
The Screen · Basic Materials · Other Precious Metals & Mining
Compañía de Minas Buenaventura S.A.A.
BVN · the NYSE · USD · Market cap $7.2B
Compañía de Minas Buenaventura S.A.A., together with its subsidiaries, engages in the exploration, development, construction, and operation of mines in Peru, the Americas, Europe, and Asia.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.19, read 2026-11-03
Ethical passes the values gate
Price26.76 USD
Fair value35.21
Ethical score70.0/100
Value readUndervaluedas of 3 Nov 2026
Our investment reviews on this name
2026-10-02Read Markdown34.70-22.9% to today ✓Markup gives way to Markdown after a 7% rise in 6 weeks
2026-08-24Read Markup32.56-17.8% to today Distribution gives way to Markup after an 8% rise in 4 weeks
2026-07-24Read Distribution30.24-11.5% to today ✓Markup gives way to Distribution after a 10% slide in 3 weeks
2026-07-02Read Markup33.42-19.9% to today First review on file: Markup
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Compañía de Minas Buenaventura S.A.A. holds its Markdown at $26.76. Consolidating, no directional conviction, held for 46 days.
As held on the ledger · 2026-11-03
Phase
Markdown · caution
Quantitative state
Consolidating, no directional conviction, held for 46 days
Price at the screen
$26.76
Valuation
6.46 trailing · 7.77 forward price to earnings
Values screen
PASS· score 70.0
Beta
0.42
The Workings
Five Screens, Shown in Full
Full pass across all five screens. This security clears the Titan Ethical Standard: its business and its balance sheet both stay inside the lines.
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
0.15%
Below 33%
Interest-bearing debt is just 0.1% of its assets, well under the one-third ceiling: it does not run on borrowed money.
Pass
Interest-bearing cash
0.00%
Below 33%
Cash held in interest-bearing accounts and securities is 0.0% of assets, under the one-third limit.
Pass
Receivables
17.64%
Below 49%
Money owed to the company is 17.6% of assets, under the 49% limit.
Pass
Revenue purity
2.74%
Below 5%
Only 2.7% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Clears, in Plain English
Compañía de Minas Buenaventura S.A.A. clears all five screens. Its business is in a permissible area, its debt is near-nil, and interest is about 3% of its income, under the ~5% line, so it passes.
Read as at 2026-11-04. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when BVN's ethical verdict changes
Today BVN passes the screen. If new figures move it to a fail, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
What the Numbers Say It Is Worth
The Fair Value Range
Our analysis reads Undervalued vs our fair value, as of 3 Nov 2026: it trades at roughly a 24% discount to our $35.21 fair value, 43.20% revenue growth.
Fair value range in USD, drawn from the 2026-11-03 screen. The gold marker is the market price at the same screen. A 24.0% discount to the base estimate.
Where our models see it going: fair-value estimate $35.21, with a range of $24.66 to $40.49, dated to the 2026-11-03 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Peru gold miner flashes margins yet cycle warns
When gold prices spike, miners in Peru can post eye watering margins overnight. Buenaventura shows revenue up 103 percent, a 48 percent profit margin and 26 percent ROE, yet the opportunity rating stays at none and the forward multiple of 8.6 times offers no real edge once the cycle fades.
The current price of 30.24 dollars sits 11 percent below our fair value with analysts holding a 37 dollar median target. Strong numbers on paper mask the fact this is a cyclical business where peak earnings often meet a low multiple and produce exactly the value trap investors later regret.
The ethical screen clears yet the unknown moat and Peru specific risks remain. Currency swings and metal price reversals can erase the apparent bargain faster than the numbers suggest.
Another profit measure, before interest, tax and non-cash costs: EBITDA.
The risks · The things to watch: its business and earnings are exposed to Peru and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
BVN trades on the NYSE (the company is based in Peru). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-11-04Markdown$26.76-5.9%Entry 10
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 5.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it none, with a mean price target of $40.
2026-10-28Markdown$28.44-8.7%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 8.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading oversold. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it none, with a mean price target of $40. Since the last review it its composite score rose.
2026-10-21Markdown$31.15-3.6%Entry 8
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 3.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it C, carrying a low risk profile. Technically it is momentum reading bearish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it none, with a mean price target of $40.
2026-10-14Markdown$32.30-6.9%Entry 7
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.9% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it none, with a mean price target of $40.
2026-10-02Markdown · changed$34.70+6.6%Entry 6
The framework has shifted from markup to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved up 6.6% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it none, with a mean price target of $40.
2026-08-24Markup · changed$32.56+7.7%Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 7.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it none, with a mean price target of $40.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 9.5% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it none, with a mean price target of $40.
2026-07-18Markup$33.42+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B, carrying a low risk profile. Technically it is holding around 22% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 33%. The street (5 analysts) rates it none, with a mean price target of $40.
2026-07-03Markup$33.42+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$33.42Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
